Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer

Clinical trial NCT05284552 · RECRUITING

Trial details

NCT number: NCT05284552
Sponsor: University Hospital, Linkoeping
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer

Start date: 2022-07-12
Primary completion: 2027-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.